市場調査レポート
商品コード
1171984

体外式膜型人工肺 (ECMO)の2028年までの市場予測 - モダリティ、用途、年齢層別の世界の分析

Extracorporeal Membrane Oxygenation Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Modality, Application, and Age Group

出版日: | 発行: The Insight Partners | ページ情報: 英文 162 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
体外式膜型人工肺 (ECMO)の2028年までの市場予測 - モダリティ、用途、年齢層別の世界の分析
出版日: 2022年11月30日
発行: The Insight Partners
ページ情報: 英文 162 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

体外式膜型人工肺 (ECMO)は、2021年の5億4673万米ドルから2028年には6億7764万米ドルに達すると予測され、2022年から2028年の間にCAGR3.1%で成長すると推測されています。

本レポートでは、市場を牽引する主な要因や、主な企業の発展についてハイライトしています。体外式膜型人工肺市場の成長は、主に心血管疾患と呼吸不全の有病率の上昇と、肺移植術における体外式膜型人工肺の採用が拡大していることに起因しています。ただし、体外式膜型人工肺に伴う合併症が市場の成長を妨げています。

心血管疾患と呼吸不全の有病率の上昇が体外式膜型人工肺市場の成長を牽引

体外式膜型人工肺(extracorporeal membrane oxygenation)は、心肺バイパス装置です。体外式膜型人工肺は、心血管疾患や呼吸不全の治療に使用されています。心血管系疾患(CVD)による死亡者数は、世界中で毎年数百万人にのぼります。CVDは欧州における死亡と罹患の主な原因となっており、欧州地域の死亡の45%、欧州連合(EU)の死亡の37%を占めています。研究「Global Burden of Disease Study 2019」によると、CVDは2019年のアジアにおける主要な死因の一つであり、1,080万人の死亡(全死亡の35%)を引き起こしています。2022年心臓病・脳卒中統計更新ファクトシート「Global Burden of Disease」によると、2020年には全世界で推定1億1910万人の患者がCVDで死亡していることが明らかになっています。また、2020年の脳卒中と虚血性脳卒中の世界有病率は、それぞれ8,910万人と6,820万人であったと記載されています。CVDの発症率が高いのは、北米です。国立慢性疾患予防・健康増進センター心臓病・脳卒中予防部門によると、米国では697,000人が心臓病で命を落としています。米国心臓協会によると、2035年までに米国の1億3,000万人以上(総人口の45.1%)が何らかの心血管系疾患に罹患する可能性があるとされています。また、国立医学図書館によると、2022年には、毎年約40万件の冠動脈バイパス移植術(CABG)が実施されています。

慢性閉塞性肺疾患(COPD)は、肺からの空気の流れが阻害され、呼吸不全に陥る病気です。世界中で数百万人の死者を出している、生命を脅かす病気の一つです。世界保健機関(WHO)によると、COPDは死因の第3位で、2019年には全世界で323万人の死亡をもたらしました。COPDによる死亡の約90%は、低・中所得国で発生しています。CDC(米国疾病対策予防センター)によると、2020年、米国における死因の第6位はCOPDでした。したがって、心血管疾患や呼吸不全の有病率の高まりは、体外膜酸素化市場の成長を牽引しています。

体外式膜型人工肺の世界市場は、モダリティに基づいて、静脈動脈性体外式膜型人工肺、静脈性体外式膜型人工肺、動静脈性体外式膜型人工肺に区分されます。静脈動脈性体外膜酸素化療法セグメントは、2021年に市場で最大のシェアを占め、予測期間中に市場で3.1%のCAGRを記録すると予測されます。静脈動脈(VA)体外膜酸素化は、患者の心臓を通さずに回路を通して血液を押し出すことで、患者の心臓と肺をサポートします。このタイプの体外式膜酸素供給法は、太い静脈から血液を取り出して太い動脈に戻すことで、心臓のポンプ機能が低下しても、酸素を豊富に含む血液を体内を循環させることができます。静脈動脈血管外体外膜酸素化術(VA-extracorporeal membrane oxygenation)は、過去10年間に広く適用されるようになりました。これは,さまざまな病因の難治性心原性ショックに対する有効かつ貴重な治療法です。病院内での心停止という特殊な状況下で有望な結果を示し、良好な神経学的転帰を伴う生存率は20~40%と報告されています。

体外式膜型人工肺の世界市場は、用途に基づいて呼吸器系と心臓系に二分されます。体外式膜酸素供給は肺不全から回復した患者に使用されるため、2021年の市場では呼吸器分野が大きなシェアを占めています。急性呼吸窮迫症候群(ARDS)、肺の肺動脈閉塞(肺塞栓症)、COVID-19は、体外式膜型人工肺が使用されるいくつかの肺疾患であり、体外式膜型人工肺は肺機能が全くない患者の身体を支えることができます。体外式膜酸素供給法は、臓器移植を待つ間、治癒が不可能な心臓病を患う人々をサポートするためにも使用されます。心臓発作(急性心筋梗塞)、心筋疾患(代償性心筋症)、心不全の治療に使用されます。WHOの発表によると、2019年、CVDによる死亡者数は1,790万人で、世界全体の死亡者数の32%を占めています。心血管疾患の有病率の増加は、今後数年間、体外膜酸素化装置の需要を増加させると思われます。

食品医薬品局、統計・計画実施省、国立統計地域研究所、国家医療品管理局は、体外膜酸素化市場のレポートを作成する際に参照した主な一次情報源および二次情報源の一部です。

目次

第1章 イントロダクション

  • 調査対象範囲
  • インサイトパートナーズの調査報告書ガイダンス
  • 市場セグメンテーション
    • 体外式膜型人工肺の世界市場:モダリティ別
    • 体外式膜型人工肺の世界市場:用途別
    • 体外式膜型人工肺の世界市場:年齢層別
    • 体外式膜型人工肺の世界市場-地域別

第2章 主要なポイント

第3章 調査手法

  • 対象範囲
  • 2次調査
  • 1次調査

第4章 体外式膜型人工肺市場:市場情勢

  • PEST分析
    • 北米のPEST分析
    • 欧州のPEST分析
    • アジア太平洋地域のPEST分析
    • 中東・アフリカのPEST分析
    • 中南米のPEST分析
  • 専門家の見解

第5章 体外式膜型人工肺市場:主な市場力学

  • 市場促進要因
    • 心血管疾患と呼吸不全の有病率の上昇
    • 肺移植手術における体外式膜型人工肺の採用拡大
  • 市場抑制要因
    • 体外式膜型人工肺に関連する合併症
  • 市場機会
    • 体外式膜型人工肺別、生存率の向上
  • 今後の動向
    • 製品開発・承認の急増
  • インパクト分析

第6章 体外式膜型人工肺の世界市場- 分析

  • 体外式膜型人工肺の世界市場:収益予測と分析
    • 体外式膜型人工肺の世界市場:収益予測と分析
  • 体外式膜型人工肺市場における主要プレイヤーの市場ポジショニング分析

第7章 体外式膜型人工肺の市場:2028年までの分析と予測(モダリティ別)

  • 体外式膜型人工肺の世界市場:モダリティ別シェア 2021年・2028年(%)
  • 静脈動脈性:体外式膜型人工肺
  • 静脈性:体外式膜型人工肺
  • 動静脈式:体外式膜型人工肺

第8章 体外式膜型人工肺市場:2028年までの分析と予測(用途別)

  • 体外式膜型人工肺の世界市場:用途別、2021年・2028年(%)
  • 心臓病学
  • 呼吸器

第9章 体外式膜型人工肺市場:2028年までの分析と予測(年齢層別)

  • 体外式膜型人工肺の世界市場:年齢グループ別、2021年・2028年(%)
  • 新生児
  • 小児科
  • 成人

第10章 体外式膜型人工肺の世界市場:2028年までの収益と予測、地域別分析

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中南米地域
    • ブラジル
    • アルゼンチン
    • その他の中南米地域
  • 中東&アフリカ
    • 南アフリカ共和国
    • サウジアラビア
    • UAE
    • その他中東地域

第11章 体外式膜型人工肺市場へのCOVID-19パンデミックの影響

  • 北米
  • 欧州
  • アジア太平洋地域
  • 中南米
  • 中東&アフリカ

第12章 体外式膜型人工肺市場:業界情勢

  • 体外式膜型人工肺市場の成長戦略
  • 無機的な成長戦略
  • 有機的成長戦略

第13章 企業プロファイル

  • Terumo Group
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • LivaNova Plc
  • Nipro Medical Corporation
  • Eurosets S.R.L.
  • Getinge AB
  • Braile Biomedica
  • Fresenius Medical Care AG & Co KGaA
  • ABIOMED Inc

第14章 付録

  • インサイト・パートナーズについて
  • 用語解説
図表

List Of Tables

  • Table 1. North America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. North America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. US Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Canada Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Mexico Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Europe: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe: Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Germany: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. UK: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. France: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. Italy: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Spain: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain: Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain: Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. China Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 40. Japan Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 43. India Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 46. South Korea Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 49. Australia Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Application- Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 55. South & Central America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. South & Central America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 57. South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 58. Brazil Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 59. Brazil Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 60. Brazil Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 61. Argentina Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 62. Argentina Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 63. Argentina Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 64. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (USD Million)
  • Table 65. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 66. Rest of South & Central America Extracorporeal Membrane Oxygenation Market, by Age Group - Revenue and Forecast to 2028 (USD Million)
  • Table 67. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 70. South Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 73. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 76. UAE Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. UAE Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. UAE Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Application - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of Middle East & Africa Extracorporeal Membrane Oxygenation Market, by Age Group- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Recent Inorganic Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • Table 83. Recent Organic Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • Table 84. Glossary of Terms

List Of Figures

  • Figure 1. Extracorporeal Membrane Oxygenation Market Segmentation
  • Figure 2. Extracorporeal Membrane Oxygenation Market, By Region
  • Figure 3. Global Extracorporeal Membrane Oxygenation Market Overview
  • Figure 4. Venoarterial Extracorporeal Membrane Oxygenation Held Largest Share for Modality Segment in Extracorporeal Membrane Oxygenation Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Extracorporeal Membrane Oxygenation Market, by Geography (US$ Million)
  • Figure 7. Global Extracorporeal Membrane Oxygenation Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Extracorporeal Membrane Oxygenation Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East & Africa: PEST Analysis
  • Figure 13. South & Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Impact Analysis
  • Figure 16. Global Extracorporeal Membrane Oxygenation Market - Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Extracorporeal Membrane Oxygenation Market - Revenue Forecast & Analysis - 2021 - 2028
  • Figure 18. Market Positioning Analysis of Key Players in Global Extracorporeal Membrane Oxygenation Market
  • Figure 19. Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)
  • Figure 20. Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 21. Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 22. Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast To 2028 (US$ Million)
  • Figure 23. Global Extracorporeal Membrane Oxygenation Market, by Application 2021 & 2028 (%)
  • Figure 24. Cardiology Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Respiratory Market Revenue and Forecasts To 2028 (US$ MN)
  • Figure 26. Global Extracorporeal Membrane Oxygenation Market, by Age Group 2021 & 2028 (%)
  • Figure 27. Neonates Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Pediatrics Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Adults Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. North America: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 31. North America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 33. US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Europe: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 37. Europe Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 39. Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 46. Asia Pacific Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 47. Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
  • Figure 48. China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. South & Central America: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 55. South & Central America Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)
  • Figure 57. Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 61. Middle East & Africa Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)
  • Figure 63. South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
  • Figure 67. Impact of COVID-19 Pandemic on North American Countries Markets
  • Figure 68. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 69. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
  • Figure 70. Impact of COVID-19 Pandemic in South & Central America Country Markets
  • Figure 71. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
  • Figure 72. Growth Strategies in the Extracorporeal Membrane Oxygenation Market
目次
Product Code: TIPHE100001219

The extracorporeal membrane oxygenation market is projected to reach US$ 677.64 million by 2028 from US$ 546.73 million in 2021; it is estimated to grow at a CAGR of 3.1% during 2022-2028.

The report highlights the key factors driving the market and prominent players with their developments. The growth of the extracorporeal membrane oxygenation market is primarily attributed to the rising prevalence of cardiovascular diseases and respiratory failures and the growing adoption of extracorporeal membrane oxygenation in lung transplantation procedures. However, complications associated with extracorporeal membrane oxygenation hinder the growth of the market.

Rising Prevalence of Cardiovascular Diseases and Respiratory Failures Drives extracorporeal membrane oxygenation Market Growth

Extracorporeal membrane oxygenation (extracorporeal membrane oxygenation) is a heart-lungs bypass machine. extracorporeal membrane oxygenation equipment is used in the treatment of cardiovascular diseases and respiratory failures. Millions of deaths due to cardiovascular diseases (CVDs) are recorded every year across the world. CVDs majorly cause mortality and morbidity in Europe, accounting for 45% of deaths in the region and 37% in the European Union (EU). As per the study 'Global Burden of Disease Study 2019,' CVDs were among the leading causes of death in Asia in 2019, causing 10.8 million fatalities (35% of the total fatalities). According to the 2022 Heart Disease & Stroke Statistical Update Fact Sheet, Global Burden of Disease, an estimated 119.1 million patients died of CVDs across the world in 2020. It also stated that the global prevalence of stroke and ischemic stroke in 2020 was 89.1 million and 68.2 million, respectively. High instances of CVDs are observed in North America. As per the National Center for Chronic Disease Prevention and Health Promotion, Division for Heart Disease and Stroke Prevention, ~697,000 people succumbed to heart disease in the US. According to the American Heart Association, over 130 million people in the US (45.1% of total population) are likely to get affected by some form of cardiovascular disease by 2035. Further, according to the National Library of Medicine, in 2022, about 400,000 coronary artery bypass grafting (CABG) surgeries are performed every year.

Chronic obstructive pulmonary disease (COPD) causes obstruction in the airflow from the lungs, which can lead to respiratory failure. It is one of the life-threatening illnesses that cause millions of deaths across the world. According to World Health Organization (WHO), COPD was the third leading cause of death, which caused 3.23 million deaths across the globe in 2019. About 90% of COPD deaths occur in low- and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, COPD was the sixth leading cause of death in the US. Therefore, the growing prevalence of cardiovascular diseases and respiratory failures drives the growth of the extracorporeal membrane oxygenation market.

The global extracorporeal membrane oxygenation market, based on modality, is segmented into venoarterial extracorporeal membrane oxygenation, venovenous extracorporeal membrane oxygenation, and arteriovenous extracorporeal membrane oxygenation. The venoarterial extracorporeal membrane oxygenation segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 3.1% in the market during the forecast period. Venoarterial (VA) extracorporeal membrane oxygenation supports the patient's heart and lungs by pushing the blood through the circuit without getting through the patient's heart. This type of extracorporeal membrane oxygenation takes blood out of a large vein and back it into a large artery, allowing oxygen-rich blood to circulate through the body even if the heart is too weak to pump. Veno-arterial extracorporeal membrane oxygenation (VA-extracorporeal membrane oxygenation) has been widely applied over the last decade. It is an effective and valuable therapeutic option in refractory cardiogenic shock of various etiologies. It showed promising results in the specific setting of in-hospital cardiac arrest, and survival rates with good neurological outcomes are reported between 20% and 40%.

Based on application, the global extracorporeal membrane oxygenation market is bifurcated into respiratory and cardiology. The respiratory segment held a larger share of the market in 2021 as extracorporeal membrane oxygenation is used for patients recovering from lung failure. Acute respiratory distress syndrome (ARDS), Blockage in a pulmonary artery in the lungs (pulmonary embolism), and COVID-19 are a few lung diseases where extracorporeal membrane oxygenation is used. extracorporeal membrane oxygenation can support patients body in total absence of lung function. However, the cardiology segment is anticipated to register a CAGR of 3. 6% in the market during the forecast period. extracorporeal membrane oxygenation is also used to support people affected by heart disease that cannot be cured while they wait for an organ transplant. It is used in the treatment of heart attack (acute myocardial infarction), heart muscle disease (decompensated cardiomyopathy), and heart failure. As per the WHO, in 2019, due to CVDs ~17.9 million deaths were recorded accounting for 32% of all global deaths. Increasing prevalence of cardiovascular diseases is likely to increase the demand for extracorporeal membrane oxygenation machines in the coming years.

Food and Drug Administration, Ministry of Statistics and Program Implementation, National Institute of Statistics and Geography, and National Medical Products Administration are a few of the major primary and secondary sources referred to while preparing the report on the extracorporeal membrane oxygenation market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the extracorporeal membrane oxygenation market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global extracorporeal membrane oxygenation market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Extracorporeal Membrane Oxygenation Market - By Modality
    • 1.3.2 Global Extracorporeal Membrane Oxygenation Market - By Application
    • 1.3.3 Global Extracorporeal Membrane Oxygenation Market - By Age Group
    • 1.3.4 Global Extracorporeal Membrane Oxygenation Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Extracorporeal Membrane Oxygenation Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East & Africa PEST Analysis
    • 4.2.5 South & Central America PEST Analysis
  • 4.3 Experts Opinion

5. Extracorporeal Membrane Oxygenation Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Cardiovascular Diseases and Respiratory Failures
    • 5.1.2 Growing Adoption of Extracorporeal Membrane Oxygenation in Lung Transplantation Procedures
  • 5.2 Market Restraints
    • 5.2.1 Complications Associated with Extracorporeal Membrane Oxygenation
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Survival Rates with Extracorporeal Membrane Oxygenation
  • 5.4 Future Trends
    • 5.4.1 Surging Product Developments and Approvals
  • 5.5 Impact Analysis

6. Extracorporeal Membrane Oxygenation Market - Global Analysis

  • 6.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
    • 6.1.1 Global Extracorporeal Membrane Oxygenation Market Revenue Forecast & Analysis
  • 6.2 Market Positioning Analysis of Key Players in Extracorporeal Membrane Oxygenation Market

7. Extracorporeal Membrane Oxygenation Market Analysis and Forecast To 2028 - By Modality

  • 7.1 Overview
  • 7.2 Global Extracorporeal Membrane Oxygenation Market Share by Modality 2021 & 2028 (%)
  • 7.3 Venoarterial Extracorporeal Membrane Oxygenation
    • 7.3.1 Overview
    • 7.3.2 Venoarterial Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Venovenous Extracorporeal Membrane Oxygenation
    • 7.4.1 Overview
    • 7.4.2 Venovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Arteriovenous Extracorporeal Membrane Oxygenation
    • 7.5.1 Overview
    • 7.5.2 Arteriovenous Extracorporeal Membrane Oxygenation: Extracorporeal Membrane Oxygenation Market Revenue and Forecast to 2028 (US$ Million)

8. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Application

  • 8.1 Overview
  • 8.2 Global Extracorporeal Membrane Oxygenation Market, By Application 2021 & 2028 (%)
  • 8.3 Cardiology
    • 8.3.1 Overview
    • 8.3.2 Cardiology Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Respiratory
    • 8.4.1 Overview
    • 8.4.2 Respiratory Market Revenue and Forecast to 2028 (US$ Mn)

9. Extracorporeal Membrane Oxygenation Market Analysis and Forecasts To 2028 - By Age Group

  • 9.1 Overview
  • 9.2 Global Extracorporeal Membrane Oxygenation Market, By Age Group 2021 & 2028 (%)
  • 9.3 Neonates
    • 9.3.1 Overview
    • 9.3.2 Neonates Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Pediatrics
    • 9.4.1 Overview
    • 9.4.2 Pediatrics Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.5 Adults
    • 9.5.1 Overview
    • 9.5.2 Adults Market Revenue and Forecast to 2028 (US$ Mn)

10. Extracorporeal Membrane Oxygenation Market Revenue and Forecasts to 2028 - Geographical Analysis

  • 10.1 North America: Extracorporeal Membrane Oxygenation Market
    • 10.1.1 Overview
    • 10.1.2 North America: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    • 10.1.4 North America: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    • 10.1.5 North America: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
    • 10.1.6 North America: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.1.6.1 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.1 Overview
        • 10.1.6.1.2 US: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.1.3 US: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.1.4 US: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.1.5 US: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.1.6.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.1 Overview
        • 10.1.6.2.2 Canada: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.2.3 Canada: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.2.4 Canada: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.2.5 Canada: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.1.6.3 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.1 Overview
        • 10.1.6.3.2 Mexico: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.6.3.3 Mexico: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.1.6.3.4 Mexico: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.1.6.3.5 Mexico: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  • 10.2 Europe: Extracorporeal Membrane Oxygenation Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    • 10.2.5 Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
    • 10.2.6 Europe: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.2.6.1 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.2.4 UK: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.2.5 UK: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.3 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.3.4 France: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.3.5 France: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.4 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.5 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Extracorporeal Membrane Oxygenation Market, By Modality, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
  • 10.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Country, 2021 & 2028 (%)
      • 10.3.6.1 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.1.4 China: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.1.5 China: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.3 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.3.4 India: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.3.5 India: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.4 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.5 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Modality, 2020-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Application, 2020-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Extracorporeal Membrane Oxygenation Market, by Age Group, 2020-2028 (US$ Million)
  • 10.4 South & Central America Extracorporeal Membrane Oxygenation Market
    • 10.4.1 Overview
    • 10.4.2 South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
    • 10.4.4 South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
    • 10.4.5 South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
    • 10.4.6 South & Central America: Extracorporeal Membrane Oxygenation, by Country, 2021 & 2028 (%)
      • 10.4.6.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Brazil: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.2 Brazil: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.1.3 Brazil: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.1.4 Brazil: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
      • 10.4.6.2 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Argentina: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.2 Argentina: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.2.3 Argentina: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Argentina: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
      • 10.4.6.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Rest of South & Central America: Extracorporeal Membrane Oxygenation - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.2 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.3.3 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Application, 2019-2028 (US$ Million)
        • 10.4.6.3.4 Rest of South & Central America: Extracorporeal Membrane Oxygenation, by Age Group, 2019-2028 (US$ Million)
  • 10.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market
    • 10.5.1 Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
    • 10.5.2 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
    • 10.5.3 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
    • 10.5.4 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
    • 10.5.5 Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Country, 2021& 2028 (%)
      • 10.5.5.1 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.1 Overview
        • 10.5.5.1.2 South Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.1.3 South Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.1.4 South Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.1.5 South Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.1 Overview
        • 10.5.5.2.2 Saudi Arabia: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.2.3 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.2.4 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.2.5 Saudi Arabia: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.3 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.1 Overview
        • 10.5.5.3.2 UAE: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.3.3 UAE: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.3.4 UAE: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.3.5 UAE: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)
      • 10.5.5.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.4.1 Overview
        • 10.5.5.4.2 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market- Revenue and Forecast to 2028 (US$ Million)
        • 10.5.5.4.3 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.5.4.4 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Application, 2019-2028 (US$ Million)
        • 10.5.5.4.5 Rest of Middle East & Africa: Extracorporeal Membrane Oxygenation Market, by Age Group, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Extracorporeal Membrane Oxygenation Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 South & Central America: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic

12. Extracorporeal Membrane Oxygenation Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Extracorporeal Membrane Oxygenation Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Terumo Group
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Medtronic Plc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 MicroPort Scientific Corporation
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 LivaNova Plc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Nipro Medical Corporation
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Eurosets S.R.L.
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Getinge AB
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Braile Biomedica
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Fresenius Medical Care AG & Co KGaA
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 ABIOMED Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms